Expanded Insurance for Weight-Loss Medications Propels Eli Lilly to a Trillion-Dollar Valuation

New York, Sunday, 31 May 2026.
CVS Health’s late May 2026 decision to restore coverage for Eli Lilly’s obesity medications has driven the pharmaceutical giant’s market valuation back into the exclusive $1 trillion club.